Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
China, Hong Kong stocks firm up; investors await US-China trade talks

2018-08-20 thehindubusinessline
The CSI300 index was up 0.2 per cent at 3,236.16 at the end of the morning session, while the Shanghai Composite Index gained 0.1 per cent to 2,671.93
0753 AICAF AIRC AIRYY 0914 CRRRF

6
HK stocks hit six-month closing low as trade war fears persist

2018-06-21 theedgemarkets
SHANGHAI (June 21): Hong Kong stocks ended at a six-month low on Thursday, as China-US trade conflict fears curbed risk appetite.
CRWOY 0390 CGHLY CRWOF 0914 CGHOF CEO 0384

6
China, Hong Kong stocks wobble on trade war fears

2018-06-21 thehindubusinessline
China and Hong Kong shares reversed earlier gains to slide on Thursday, as concerns over a trade spat between China and the United States weighed on sentiment.
1336 CGHLY JINDALSAW 0914 500378 CGHOF CEO 1088 0384

0
China stocks extend slump on trade war fears; Hong Kong up

2018-06-20 reuters
SHANGHAI, June 20 (Reuters) - China stocks fell on Wednesday, extending a rout from the previous day, as Washington and Beijing stepped up their heated exchange over tariffs that are fuelling worries of an all-out trade war.
GGDVF GGDVY 2313 SZHIF HUNGF 0914 HNP 0902 0270

48
The Zacks Analyst Blog Highlights: Zebra Technologies, Anhui Conch Cement and Graco

2018-06-05 zacks
Chicago, IL – June 5, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Zebra Technologies (ZBRA - Free Report) , Anhui Conch Cement (AHCHY - Free Report) and Graco (GGG - Free Report) .
WLH CCS DB AMC BNPQY WLK CTXS ASYS ZBRA BNPQF CRARF CDNS BNPZY WLS DK GGG MGA MG MLNX TTEK ACA MKSI 0914 CRARY

10
What of Deutsche Bank and Europe's Other Banks?

2018-06-04 zacks
Here are Reuters in London’s five big world market themes. These are likely to dominate the thinking of investors and traders in the coming week.
BNPZY DB GGG BNPQY ACA 0914 ZBRA BNPQF CRARY CRARF

0
Hong Kong stocks rise as financials climb

2018-04-30 thehindubusinessline
Hong Kong’s main Hang Seng index rose to a more than one-week high by lunch break on Monday, as strength in overseas markets provided support, with banks and financial stocks leading the charge, while China's H-shares index climbed to an over two-week high.
3968 0914 1088

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...